SNCA and Parkinson disease: Pathological protein aggregates comprising tau in tauopathies or alpha-synuclein (αSyn) in Parkinson’s disease (PD) [6] first appear in a specific brain region and, as disease progresses, spread to other areas of the brain following neuroanatomical pathways.